Table 1 Demographic and clinical characteristics of kidney transplant patients

Age (Year)ⁱ

45.75 ± 3.58

38.10 ± 4.80

53.40 ± 4.27

Sex ^j

Male

female

14 (70%)

6 (30%)

6 (60%)

4 (40%)

8 (80%)

2 (20%)

HCMV IgG (IU/ml)ⁱ

8.08 ± 0.14

7.91 ± 0.26

8.25 ± 0.06

Living donor Tx ^{d j}

Related ^j

Unrelated ^j

5 (25%)

2 (10%)

3 (15%)

3 (30%)

1 (10%)

2 (20%)

2 (20%)

1 (10%)

1(10%)

Dialysis prior to Tx ^j

12 (60%)

5 (50%)

7 (70%)

Types of dialysis ^j

HD^e

PD^f

11 (55%)

1 (5%)

4 (40%)

1 (10%)

7 (70%)

0

Time on dialysis (Months)ⁱ

20.18 ± 3.72

15.20 ± 6.61

24.33 ± 3.76

Rejection ^j

Acute rejection

Chronic rejection

15 (75%)

9 (45%)

6 (30%)

8 (80%)

5 (50%)

3 (30%)

7 (70%)

4 (40%)

3 (30%)

Induction therapy ^j

ATG ^{g j} (1.5 mg/kg)

ATG + Basiliximab ^j (20 mg)

12 (60%)

10 (50%)

2 (10%)

6 (60%)

6 (60%)

0

6 (60%)

4 (40%)

2 (20%)

ESRD^h etiology ^j

Hypertension

Diabetes mellitus

Glomerulonephritis

16 (80%)

2 (10%)

1 (5%)

9 (90%)

0

1 (10%)

7 (70%)

2 (20%)

0

Clinical parametersⁱ

BUN (mg/dL)

Cr (mg/dL)

Na (mmol/L)

K (mmol/L)

Ca (mg/dL)

P (mg/dL)

Mg (mmol/L)

Uric A. (mg/dL)

FBS (mg/dL)

WBC (×10³/mm³)

Hb (g/dL)

HCT (%)

Plt (×10⁹/L)

37.75 ± 3.40

3.00 ± 0.40

137 ± 1.07

4.19 ± 0.16

8.16 ± 0.13

4.04 ± 0.14

1.81 ± 0.06

6.58 ± 0.33

100.10 ± 6.97

8.12 ± 0.53

9.89 ± 0.46

30.77 ± 1.39

195.20 ± 25.25

32.50 ± 4.50

2.10 ± 0.32

139.30 ± 1.30

4.37 ± 0.24

8.11 ± 0.15

3.89 ± 0.15

1.87 ± 0.08

6.30 ± 0.53

87 ± 5.41

9.10 ± 0.60

9.59 ± 0.49

30.01 ± 1.62

236.50 ± 41.60

43.00 ± 4.73

3.90 ± 0.64

136.20 ± 1.62

4.01 ± 0.23

8.22 ± 0.21

4.20 ± 0.23

1.76 ± 0.09

6.86 ± 0.40

113.20 ± 11.75

7.15 ± 0.80

10.20 ± 0.79

31.53 ± 2.33

153.90 ± 24.12

0.08

0.03

0.29

0.51

0.66

0.24

0.26

0.44

0.04

0.09

0.75

0.80

0.31